Skip to Content


Active Substance: saquinavir
Common Name: saquinavir
ATC Code: J05AE01
Marketing Authorisation Holder: Roche Registration Ltd.
Active Substance: saquinavir
Status: Withdrawn
Authorisation Date: 1998-08-20
Therapeutic Area: HIV Infections
Pharmacotherapeutic Group: Antivirals for systemic use

Therapeutic Indication

Fortovase is indicated for treatment of HIV-1 infected adult patients. Fortovase should only be given in combination with ritonavir and other antiretroviral medicinal products (see section 4.2).

The marketing authorisation for Fortovase has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.